ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Abstract: TH-PO425

Combination of Cholecalciferol and Omega-3 Fatty Acid Increases 1, 25 Dihydroxy Vitamin D Level by Inhibiting 24-Hydroxylase of Kidney and Liver in 5/6 Nephrectomized Rats

Session Information

Category: Nutrition, Inflammation, and Metabolism

  • 1401 Nutrition, Inflammation, Metabolism

Authors

  • Lee, Su mi, Dong-A University, Busan, Not Applicable, Korea (the Republic of)
  • Choi, Hyuck jae, Dong-A University, Busan, Not Applicable, Korea (the Republic of)
  • Kim, Kitae, BHS Han Seo Hospital, Busan, Korea (the Republic of)
  • Son, Sung Hyun, BHS Han Seo Hospital, Busan, Korea (the Republic of)
  • Son, Young ki, Dong-A University, Busan, Not Applicable, Korea (the Republic of)
  • Kim, Seong Eun, Dong-A University, Busan, Not Applicable, Korea (the Republic of)
  • An, Won Suk, Dong-A University, Busan, Not Applicable, Korea (the Republic of)
Background

The 1α-hydroxylase (CYP27b1) and 24-hydroxylase (CYP24) in renal proximal tubules primarily involve vitamin D metabolsim. Increased activity of CYP24 contributes vitamin D metabolism in chronic kidney disease (CKD). Recent reports showed that CYP27b1 was strongly expressed in monocytes developing into hepatic macrophages and omega-3 fatty acid (FA) elevated 1, 25-dihydroxy vitamin D level in dialysis patients with scanty renal function. In this study, we evaluated whether the effect of omega-3 FA and cholecalciferol on vitamin D metabolism are related with the activity of CYP27b1 and CYP24 in liver and kidney of 5/6 nephrectomy (Nx) rat model.

Methods

Male Sprague Dawley rats were divided into five groups and treated for 6 weeks: sham control (0.9% saline), 5/6 Nx control (0.9% saline), 5/6 Nx treated with vitamin D (cholecalciferol 3000 IU/kg/week by gastric gavage), 5/6 Nx treated with omega-3 FA (300 mg/kg/day by gastric gavage), 5/6 Nx treated with vitamin D and omega-3 FA. CYP27b1 and CYP24 in remnant kidney and liver were measured by western blot analysis.

Results

Serum BUN and creatinine were the lowest in 5/6 Nx group treated with omega-3 FA and vitamin D among other 5/6 Nx groups. The levels of serum 1, 25-dihydroxy vitamin D and 25-hydroxy vitamin D were the highest in 5/6 Nx group treated with omega-3 FA and vitamin D among other 5/6 Nx groups. The expression of CYP24 was significantly increased in remnant kidney and liver of 5/6 Nx control compared to sham control. Increased expression of CYP24 in remnant kidney and liver of 5/6 Nx control was significantly decreased by combined treatment with omega-3 FA and cholecalciferol. The expression of CYP27b1 was significantly increased in remnant kidney and significantly decreased in liver of 5/6 Nx control compared to sham control. The increased expression of CYP27b1 in remnant kidney and decreased expression of CYP27b1 in liver of 5/6 Nx control was nearly normalized by combined treatment with omega-3 FA and vitamin D.

Conclusion

Combined treatment with omega-3 FA and cholecalciferol definitely increases 1, 25-dihydroxy vitamin D level by inhibiting expression of 24-hydroxylase in remnant kidney and liver and activating expression of 1 α-hydroxylase in liver of 5/6 Nx rats.